𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

✍ Scribed by Ignacio Cruz-Gonzalez; Maria Sanchez-Ledesma; Suzanne J. Baron; Josephine L. Healy; Hikari Watanabe; Masanori Osakabe; Robert W. Yeh; Ik-Kyung Jang

Publisher
Springer US
Year
2007
Tongue
English
Weight
138 KB
Volume
25
Category
Article
ISSN
0929-5305

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stenting and glycoprotein IIb/IIIa inhib
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)
✍ Gilles Montalescot; Frans Van de Werf; Dietrich C. Gulba; Álvaro Avezum; David B πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

## Abstract Stenting and GP IIb/IIIa inhibition are promising adjunctive therapies in PCI. The Global Registry of Acute Coronary Events (GRACE) is a registry of unselected patients with acute coronary syndromes, allowing for the study of treatments in a real‐world environment. Data from GRACE patie